Peer-influenced content. Sources you trust. No registration required. This is HCN.
Oncology News Central (ONC)
“Emerging data from this confirmatory study have highlighted a safety profile that is unfavorable compared to that previously observed in clinical evaluation.” — Christelle Huguet, PhD, Ipsen
Hematology/Oncology March 17th 2026
Cancer Therapy Advisor
The brothers falsely inflated OP-1250’s overall response rate from 9% to 17% and bumped up the expected phase II response rate from 18% to 36%.
Oncology Pharmacy February 2nd 2026
Epoch Health
“Patients and doctors [lack] enough research to inform medical guidelines and many patients are using these products without talking to their doctor about them.” —Senior White House official
Family Medicine/General Practice January 21st 2026
Providers nationwide are experiencing an uptick in health plans denying payments by improperly asserting that providers are not coding their claims correctly.
Hematology/Oncology November 17th 2025